
To the Editor.— Warnings have repeatedly been raised regarding the possibility of rebound hypertension following the abrupt cessation of therapy with clonidine hydrochloride. 1-6 While reports have suggested this as a possibility, they have largely been little more than individual case reports with no pretreatment blood pressure observations for comparison with the values obtained after cessation of clonidine administration. To our knowledge, there have been no studies specifically designed to ascertain the possibility of rebound hypertension. We have designed a study to specifically evaluate the possibility of rebound hypertension in patients who have been receiving clonidine for three days, and then again for four weeks. To date, 12 patients with a mild to moderate degree of essential hypertension have completed the protocol. The blood pressure findings thus far are summarized in the Table. At this point, there has been no evidence of rebound hypertension after abrupt cessation of clonidine use.
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
